Animal models for the preclinical evaluation of candidate influenza vaccines. (Q30383623)

21 June 2017

1 reference

title

Animal models for the preclinical evaluation of candidate influenza vaccines. (English)

1 reference

21 June 2017

3

Albert D M E Osterhaus

1 reference

21 June 2017

Rogier Bodewes

1

0 references

Guus Rimmelzwaan

series ordinal

2

object named as

Guus F Rimmelzwaan

1 reference

21 June 2017

publication date

1 January 2010

1 reference

Expert Review of Vaccines

21 June 2017

published in

1 reference

21 June 2017

volume

9

1 reference

21 June 2017

issue

1

1 reference

21 June 2017

page(s)

59-72

1 reference

Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Possible origin of current influenza A H1N1 viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Probable person-to-person transmission of avian influenza A (H5N1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Avian-to-human transmission of H9N2 subtype influenza A viruses: relationship between H9N2 and H5N1 human isolates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Global patterns of influenza a virus in wild birds

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Transmission of equine influenza virus to dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Avian influenza in birds and mammals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Highly pathogenic avian influenza H5N1 virus in cats and other carnivores

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Influenza type A in humans, mammals and birds: determinants of virus virulence, host-range and interspecies transmission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Sialic acid species as a determinant of the host range of influenza A viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

H5N1 Virus Attachment to Lower Respiratory Tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

The NS1 gene of H5N1 influenza viruses circumvents the host anti-viral cytokine responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Pathogenicity of highly pathogenic avian influenza virus in mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Lethal H5N1 influenza viruses escape host anti-viral cytokine responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Human infection with highly pathogenic H5N1 influenza virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Pathology, molecular biology, and pathogenesis of avian influenza A (H5N1) infection in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Adaptation of human influenza H3N2 virus in a mouse pneumonitis model: insights into viral virulence, tissue tropism and host pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Multiple amino acid substitutions are involved in the adaptation of H9N2 avian influenza virus to mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

H5N1 viruses and vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Protection of mice against lethal infection with highly pathogenic H7N7 influenza A virus by using a recombinant low-pathogenicity vaccine strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Host genetic variation affects resistance to infection with a highly pathogenic H5N1 influenza A virus in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Genetic susceptibility and resistance to influenza infection and disease in humans and mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Recombinant modified vaccinia virus Ankara-based vaccine induces protective immunity in mice against infection with influenza virus H5N1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Strain differences in sleep patterns of healthy and influenza-infected inbred mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Gene expression in lung and basal forebrain during influenza infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

The cotton rat provides a useful small-animal model for the study of influenza virus pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

The cotton rat model of respiratory viral infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Lung alterations in guinea-pigs infected with influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Influenza virus infection of the guinea pig: Immune response and resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

The guinea pig as a transmission model for human influenza viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Pathogenesis of 1918 pandemic and H5N1 influenza virus infections in a guinea pig model: antiviral potential of exogenous alpha interferon to reduce virus shedding

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Bronchointerstitial pneumonia in guinea pigs following inoculation with H5N1 high pathogenicity avian influenza virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Transmission of influenza virus in a mammalian host is increased by PB2 amino acids 627K or 627E/701N.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Histopathology and growth kinetics of influenza viruses (H1N1 and H3N2) in the upper and lower airways of guinea pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Pathogenesis and transmission of the novel swine-origin influenza virus A/H1N1 after experimental infection of pigs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Avian and swine influenza viruses: our current understanding of the zoonotic risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Domestic pigs have low susceptibility to H5N1 highly pathogenic avian influenza viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Avian H5N1 influenza in cats

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Influenza A virus (H5N1) infection in cats causes systemic disease with potential novel routes of virus spread within and between hosts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Subclinical infection with avian influenza A (H5N1) virus in cats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

A Virus Obtained from Influenza Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Assessment of signs of influenza illness in the ferret model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Ferrets as a transmission model for influenza: sequence changes in HA1 of type A (H3N2) virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Lack of transmission of H5N1 avian-human reassortant influenza viruses in a ferret model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Lethality to ferrets of H5N1 influenza viruses isolated from humans and poultry in 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Pathogenesis of avian influenza A (H5N1) viruses in ferrets

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Oseltamivir prophylactic regimens prevent H5N1 influenza morbidity and mortality in a ferret model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Cross-protection against lethal H5N1 challenge in ferrets with an adjuvanted pandemic influenza vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Bacterial sinusitis and otitis media following influenza virus infection in ferrets

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Integrated molecular signature of disease: analysis of influenza virus-infected macaques through functional genomics and proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

IL-15 is superior to IL-2 in the generation of long-lived antigen specific memory CD4 and CD8 T cells in rhesus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Integration of clinical data, pathology, and cDNA microarrays in influenza virus-infected pigtailed macaques (Macaca nemestrina)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Pathogenesis of influenza A (H5N1) virus infection in a primate model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Pathology of Human Influenza A (H5N1) Virus Infection in Cynomolgus Macaques (Macaca fascicularis)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Recombinant modified vaccinia virus Ankara expressing the hemagglutinin gene confers protection against homologous and heterologous H5N1 influenza virus infections in macaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

A vaccine prepared from a non-pathogenic H5N1 avian influenza virus strain confers protective immunity against highly pathogenic avian influenza virus infection in cynomolgus macaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Blocking interhost transmission of influenza virus by vaccination in the guinea pig model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Influenza virus transmission: basic science and implications for the use of antiviral drugs during a pandemic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Superior immunogenicity of inactivated whole virus H5N1 influenza vaccine is primarily controlled by Toll-like receptor signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Immunization with the adjuvant MF59 induces macrophage trafficking and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Highly conserved pattern of recognition of influenza A wild-type and variant CD8+ CTL epitopes in HLA-A2+ humans and transgenic HLA-A2+/H2 class I-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Broad influenza-specific CD8+ T-cell responses in humanized mice vaccinated with influenza virus vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Gene expression analysis of host innate immune responses during Lethal H5N1 infection in ferrets

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Cloning, expression and immunoassay detection of ferret IFN-gamma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Molecular cloning and phylogenetic analysis of inflammatory cytokines of the ferret (Mustela putorius furo).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Severe seasonal influenza in ferrets correlates with reduced interferon and increased IL-6 induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

DNA vaccination of ferrets with chimeric influenza A virus hemagglutinin (H3) genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Evaluation of vaccines for H5N1 influenza virus in ferrets reveals the potential for protective single-shot immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Immunization with reverse-genetics-produced H5N1 influenza vaccine protects ferrets against homologous and heterologous challenge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Cross-protectiveness and immunogenicity of influenza A/Duck/Singapore/3/97(H5) vaccines against infection with A/Vietnam/1203/04(H5N1) virus in ferrets

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Plasmid DNA-based vaccines protect mice and ferrets against lethal challenge with A/Vietnam/1203/04 (H5N1) influenza virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Vaccination against measles: a neverending story

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Vaccination of macaques with adjuvanted formalin-inactivated influenza A virus (H5N1) vaccines: protection against H5N1 challenge without disease enhancement

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Immunogenicity and protective efficacy of a live attenuated H5N1 vaccine in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Immunization of primates with a Newcastle disease virus-vectored vaccine via the respiratory tract induces a high titer of serum neutralizing antibodies against highly pathogenic avian influenza virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Influenza virus subtype cross-reactivities of haemagglutination inhibiting and virus neutralising serum antibodies induced by infection or vaccination with an ISCOM-based vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

A single dose of an ISCOM influenza vaccine induces long-lasting protective immunity against homologous challenge infection but fails to protect Cynomolgus macaques against distant drift variants of influenza A (H3N2) viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Efficacy of vaccination of pigs with different H1N1 swine influenza viruses using a recent challenge strain and different parameters of protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Correlations between lung proinflammatory cytokine levels, virus replication, and disease after swine influenza virus challenge of vaccination-immune pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Vaccination of pigs against swine influenza viruses by using an NS1-truncated modified live-virus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Protection of weaned pigs by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of H3N2 swine influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Avian influenza vaccines and therapies for poultry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Vaccination against equine influenza: quid novi?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Heterologous protection against influenza by injection of DNA encoding a viral protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Current progress of DNA vaccine studies in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

M2e-based universal influenza A vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

MF59 is a safe and potent vaccine adjuvant that enhances protection against influenza virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Antigenically distinct MF59-adjuvanted vaccine to boost immunity to H5N1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

MF59 is a safe and potent vaccine adjuvant for flu vaccines in humans: what did we learn during its development?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

A broadly protective vaccine against globally dispersed clade 1 and clade 2 H5N1 influenza viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Safety and immunogenicity of adenovirus-vectored nasal and epicutaneous influenza vaccines in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Report of a consultation on role of immunological assays to evaluate efficacy of influenza vaccines. Initiative for Vaccine Research and Global Influenza Programme, World Health Organization, Geneva, Switzerland, 25 January 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Phenotypic analysis of antigen-specific T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

A previously unrecognized H-2D(b)-restricted peptide prominent in the primary influenza A virus-specific CD8(+) T-cell response is much less apparent following secondary challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Comparative Susceptibility of Selected Avian and Mammalian Species to a Hong Kong–Origin H5N1 High-Pathogenicity Avian Influenza Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Studies of H5N1 influenza virus infection of pigs by using viruses isolated in Vietnam and Thailand in 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Pathogenicity of a highly pathogenic avian influenza virus, A/chicken/Yamaguchi/7/04 (H5N1) in different species of birds and mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Highly pathogenic avian influenza virus (H5N1) infection in red foxes fed infected bird carcasses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

Experimental infection of cattle with highly pathogenic avian influenza virus (H5N1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.148

21 January 2018

Identifiers

DOI

10.1586/ERV.09.148

1 reference

21 June 2017

1 reference